RCUS
Arcus Biosciences Inc.
Company Overview
| Mkt Cap | $2.12B | Price | $19.72 |
| Volume | 5.33M | Change | -2.33% |
| P/E Ratio | -7.5 | Open | $18.54 |
| Revenue | $258.0M | Prev Close | $20.19 |
| Net Income | $-283.0M | 52W Range | $6.50 - $22.11 |
| Div Yield | N/A | Target | $31.27 |
| Overall | 71 | Value | 60 |
| Quality | -- | Technical | 83 |
No chart data available
Stock Overview
Updated DailyArcus Biosciences Inc. (RCUS) is a leading Healthcare company in the Biotechnology industry, currently trading at $19.72 with a market capitalization of $2.12 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows RCUS with a volume of 5.33 million shares. The stock opened down 8.17% from yesterday's close of $20.19. Current analyst estimates project earnings of $-3.7 per share for this year, with next year targeting $-4.05.
RCUS demonstrates very strong technical momentum based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for RCUS include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 58.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:30 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RCUS | $19.72 | -2.3% | 5.33M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |